Apple’s First Cut in Decades, Bristol-Myers Squibb to Buy Celgene, NRA’s Push Abroad
Gene Munster, Co-Founder at Loup Ventures discusses why he is still positive on Apple after the company cut its revenue outlook for the first time in almost two decades. Brian Skorney, Biotech Analyst at Baird, breaks down Bristol-Myers Squibb’s $74 billion acquisition of drug maker Celgene. Neil Weinberg, Bloomberg News Senior Projects a Investigations Reporter, shares his story in Businessweek Magazine about the NRA pushing their pro-gun agenda abroad. Vinny Catalano, CIO at Redmount Capital Partners, talks about seeing a market correction without a recession coming. And We Drive to the Close of Markets with David Dietze, Chief Investment Strategist at Point View Wealth Management. Hosts: Carol Massar and Jason Kelly. Producer: Paul Brennan